BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9314560)

  • 21. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells.
    Chen W; Jin W; Wahl SM
    J Exp Med; 1998 Nov; 188(10):1849-57. PubMed ID: 9815262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell anergy.
    Schwartz RH
    Annu Rev Immunol; 2003; 21():305-34. PubMed ID: 12471050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral immune tolerance blocks clonal expansion but fails to prevent the differentiation of Th1 cells.
    Malvey EN; Jenkins MK; Mueller DL
    J Immunol; 1998 Sep; 161(5):2168-77. PubMed ID: 9725208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.p. antigen administration.
    Ratts RB; Arredondo LR; Bittner P; Perrin PJ; Lovett-Racke AE; Racke MK
    Int Immunol; 1999 Dec; 11(12):1881-8. PubMed ID: 10590253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance.
    Schwarz A; Beissert S; Grosse-Heitmeyer K; Gunzer M; Bluestone JA; Grabbe S; Schwarz T
    J Immunol; 2000 Aug; 165(4):1824-31. PubMed ID: 10925260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allochimeric class I MHC protein-induced tolerance by partial TCR engagement requires activation of both CTL4- and common gamma-chain-dependent cytokine signals.
    Stepkowski SM; Kirken RA; Trawick BW; Wang M; Tejpal N; Wang ME; Tian L; Clark J; Kahan BD
    Transplantation; 2002 Apr; 73(8):1227-35. PubMed ID: 11981413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of hapten-specific tolerance of human CD8+ urushiol (poison ivy)-reactive T lymphocytes.
    Kalish RS; Wood JA
    J Invest Dermatol; 1997 Mar; 108(3):253-7. PubMed ID: 9036920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells.
    Kuhns MS; Epshteyn V; Sobel RA; Allison JP
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12711-6. PubMed ID: 11050166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production.
    Feng T; Qin H; Wang L; Benveniste EN; Elson CO; Cong Y
    J Immunol; 2011 Jun; 186(11):6313-8. PubMed ID: 21531892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
    Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
    Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CTLA-4 is required for the induction of high dose oral tolerance.
    Samoilova EB; Horton JL; Zhang H; Khoury SJ; Weiner HL; Chen Y
    Int Immunol; 1998 Apr; 10(4):491-8. PubMed ID: 9620605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
    Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
    J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation.
    Kato T; Nariuchi H
    J Immunol; 2000 Apr; 164(7):3554-62. PubMed ID: 10725710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD2 regulates responsiveness of activated T cells to interleukin 12.
    Gollob JA; Li J; Reinherz EL; Ritz J
    J Exp Med; 1995 Sep; 182(3):721-31. PubMed ID: 7544396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contributions of T-cell anergy to peripheral T-cell tolerance.
    Lechler R; Chai JG; Marelli-Berg F; Lombardi G
    Immunology; 2001 Jul; 103(3):262-9. PubMed ID: 11454055
    [No Abstract]   [Full Text] [Related]  

  • 38. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
    Boussiotis VA; Freeman GJ; Gribben JG; Daley J; Gray G; Nadler LM
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11059-63. PubMed ID: 7504293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion, but not anergy, is involved in TGF-beta-treated antigen-presenting cell-induced tolerance.
    Alard P; Clark SL; Kosiewicz MM
    Int Immunol; 2003 Aug; 15(8):945-53. PubMed ID: 12882832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell anergy and costimulation.
    Appleman LJ; Boussiotis VA
    Immunol Rev; 2003 Apr; 192():161-80. PubMed ID: 12670403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.